Papers and articles
ELEVECTA™ transient cell line
For viral vector production.
ELEVECTA™ transient cell line
For viral vector production.
Choose your product
Variant
Select variant
ELEVECTA™ transient cell line
To buy, choose your product.
Price includes standard shipping and handling
Overview
The ELEVECTA™ transient cell line is a flexible option for producing viral vectors using triple transfection. It’s designed to minimize development time and quickly advance promising candidates to clinical trials.
- Excellent performance: Achieve high titers of infectious virus, which can be boosted further by using enhancers.
- Enhanced product quality: Reduce encapsidated host cell DNA, which is resistant to nucleases.
- Innovative: Access advances in cell line engineering across the entire portfolio to support transition between cell lines as your needs evolve.
- Collaborative: We’re more than a supplier. Benefit from a comprehensive suite of regulatory support services designed to expedite your success in advancing to and through clinical trials.
Order now or contact us at ELEVECTA@cytiva.com to speak directly to our specialists.
The ELEVECTA™ transient cell line is part of the ELEVECTA™ cell line porftolio. This portfolio combines innovative design and deep expertise to deliver transient, packaging, and producer options that provide high quality and the flexibility to transition as needs evolve. Interconnected through their common parental cell line, the three options create a complete cell line portfolio, supporting regulatory and quality uniformity.
Product specifications
Showing 2 products
ELEVECTA transient cell line – GMP
ETCL-GMP
Stock on request
On request
ELEVECTA transient cell line – For research only
ETCL-RUO
Stock on request
On request
Product availability is not guaranteed and subject to change.
